BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Holistic medicine
,
Fluoxetine
,
rs2300478
,
IGF1
,
Coagulation
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NLRC4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Bone marrow
Rectum colon
Ascending colon
Transverse colon
Sigmoid colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Sepsis due to Escherichia coli
Bacteremia
Septicemia due to Klebsiella
Shock
Turner syndrome
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carrageenan
Copaxone
Antimycin A
Bromcresol Green
DLL4 protein, human
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SRSF3
SALL1
RBBP7
PVT1
smad4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
NLRC4-mediated pyroptosis was involved in coagulation disorders of acute pancreatitis.
FlgM is required to evade NLRC4-mediated host protection against flagellated Salmonella.
Atg16l2 augments Nlrc4 inflammasome activation by facilitating NAIPs-NLRC4 association.
LNCGM1082-mediated NLRC4 activation drives resistance to bacterial infection.
Increased reactive astrocytes and NLRC4-mediated neuronal pyroptosis in advanced visual structures c…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency as Open Label Extension
MASter-1 Study to Evaluate the Efficacy and Safety of MAS825 in NLRC4-GOF Patients
Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, S…
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
(NOD)-Like Receptors CARD Domain-Containing 4 Levels in Individuals With Periodontitis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ